News
12h
Barchart on MSNWest Pharmaceutical Services Earnings Preview: What to ExpectExton, Pennsylvania-based West Pharmaceutical Services, Inc. (WST) designs, manufactures, and sells containment and delivery ...
With Q4 behind us, let’s have a look at West Pharmaceutical Services (NYSE:WST) and its peers. Companies specializing in drug development inputs and services play a crucial role in the ...
Thrivent Financial for Lutherans Sells 8,115 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)
Thrivent Financial for Lutherans reduced its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 43.3% in the 4th quarter, according to the company in its most recent ...
This review was commissioned by NHS England in October 2022. The report looks at the full economic costs of delivering NHS pharmaceutical services, and how these costs vary across and within: ...
StockStory.org on MSN17d
Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services StocksEarnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at West Pharmaceutical Services (NYSE:WST) and its peers. Companies ...
Over the past two decades, I’ve observed significant shifts in the life sciences, pharmaceutical, and CDMO landscape. Pharmaceutical companies and their outsourcing partners must continuously ...
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
It began trading fully in 1987. In 1995, Shire made its first acquisition of another Hampshire-based business called Imperial Pharmaceutical Services. This acquisition brought to Shire a range of ...
7d
24/7 Wall St. on MSN4 Blue Chip Pharmaceutical High-Yield Dividend Stocks Are Tariff WinnersLarge-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results